As of 28 Aug 2026, ERIS Lifesciences Ltd share price is ₹1,311.65. The stock opened at ₹1,311.65 and had closed at ₹1,308.70 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,237.90 and a high of ₹1,819.25. In terms of performance, ERIS Lifesciences Ltd share price has decreased by 4.97% over the past six months and has decreased by 27.12% over the last year.
ERIS Charts
ERIS Lifesciences Ltd Overview
About ERIS
ERIS Lifesciences manufactures, markets, and sells generic drugs. The Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India.
ERIS Lifesciences Ltd Historical Performance
ERIS Lifesciences Ltd Fundamental Analysis
ERIS Lifesciences Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 470.37 | 304.28 | 340.36 | 674.09 | 601.32 |
| EBITDA | 146.28 | 48.75 | 87.75 | 320.47 | 239.00 |
| Net Profit | 48.30 | -8.60 | 3.09 | 149.57 | 99.99 |
| EPS | 3.49 | -0.63 | 0.23 | 10.98 | 7.34 |
ERIS Lifesciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 33.68 |
| MACD | -24.89 |
| 20-Day SMA | 1,357.59 |
ERIS Lifesciences Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
ERIS Lifesciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of ERIS Lifesciences Ltd today is ₹1,311.65 on NSE and ₹1,311.65 on BSE.
- The 52-week high of ERIS Lifesciences Ltd is ₹1,819.25, while the 52-week low is ₹1,237.90.
- The current market capitalisation of ERIS Lifesciences Ltd is approximately ₹18,177 crore.
- The P/E (Price-to-Earnings) ratio of ERIS Lifesciences Ltd is 39.95. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of ERIS Lifesciences Ltd is 5.35. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in ERIS Lifesciences Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for ERIS Lifesciences Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, ERIS Lifesciences Ltd has delivered a return of approximately 63.91%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of ERIS Lifesciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 54.14% promoters, -13.13% FIIs, 20.72% DIIs, and 10.10% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
